Novartis Korea announced that they resume domestic supply of 'Theraflu' in late July
On July 28, Novartis Korea announced that they resume domestic supply of 'Theraflu' in late July.
Theraflu is a new concept cold medicine taking the form of tea which was introduced for the first time in Korea in 2008. As a leader of tea-type cold medicine, it improved the new market and has sho...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
